390 (PB-023) - Efficacy of CDK 4/6 inhibition after fulvestrant in metastatic breast cancer

Autor: Hoste, G., Punie, K., Wildiers, H., Neven, P., Vergote, I., Beuselinck, B., Concin, N., Han, S., Van Nieuwenhuysen, E., Salihi, R., Smeets, A., Berteloot, P., Lefever, I., Nevelsteen, I., Van Limbergen, E., Weltens, C., Janssen, H.
Zdroj: In European Journal of Cancer April 2018 92 Supplement 3:S111-S112
Databáze: ScienceDirect